Cargando…
Gut microbiota and microbiota-derived metabolites in cardiovascular diseases
Cardiovascular diseases, including heart failure, coronary artery disease, atherosclerosis, aneurysm, thrombosis, and hypertension, are a great economic burden and threat to human health and are the major cause of death worldwide. Recently, researchers have begun to appreciate the role of microbial...
Autores principales: | Chen, Xiaofeng, Zhang, Hua, Ren, Sichong, Ding, Yangnan, Remex, Naznin Sultana, Bhuiyan, Md. Shenuarin, Qu, Jiahua, Tang, Xiaoqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538883/ https://www.ncbi.nlm.nih.gov/pubmed/37442759 http://dx.doi.org/10.1097/CM9.0000000000002206 |
Ejemplares similares
-
Sigmar1’s Molecular, Cellular, and Biological Functions in Regulating Cellular Pathophysiology
por: Aishwarya, Richa, et al.
Publicado: (2021) -
Gut microbiota derived metabolites in cardiovascular health and disease
por: Wang, Zeneng, et al.
Publicado: (2018) -
Sigmar1 ablation leads to lung pathological changes associated with pulmonary fibrosis, inflammation, and altered surfactant proteins levels
por: Remex, Naznin Sultana, et al.
Publicado: (2023) -
Gut microbiota and microbiota-derived metabolites promotes endometriosis
por: Chadchan, Sangappa B., et al.
Publicado: (2023) -
Effects of Metabolites Derived From Gut Microbiota and Hosts on Pathogens
por: Li, Zhendong, et al.
Publicado: (2018)